# Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay

> **NCT06864494** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 60 (estimated)

## Conditions studied

- Adenomyosis
- Endometriosis

## Interventions

- **PROCEDURE:** Endometrial ablation

## Key facts

- **NCT ID:** NCT06864494
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-25
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864494, "Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06864494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*